New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 11, 2014
UP AFTER EARNINGS: DealerTrack (TRAK), up 11.3%... DTS Inc. (DSTI), up 12.8%... Globalstar (GSAT), up 1.6%... Halozyme Therapeutics (HALO), up 2.4%. ALSO HIGHER: Intercept Pharmaceuticals (ICPT), up 57.7% after announcing that 46% of OCA group met FLINT endpoint as well as reporting second quarter results... Cempra (CEMP), up 5.8% following Intercept Pharmaceuticals' FLINT announcement... Scotts Miracle-Gro (SMG), up 3.6% after board approves a $500M share repurchase authorization and announces a $2.00 per share special dividend. DOWN AFTER EARNINGS: Galena Biopharma (GALE), down 13.4%... Nuance Communications (NUAN), down 9.7%... Millennial Media (MM), down 7.1%... MasTec (MTZ), down 3.6%... Turtle Beach (HEAR), down 3.5%... magicJack (CALL), down 5.8%... Geron (GERN), down 2.4%. ALSO LOWER: Sprouts Farmers Market (SFM), down 3.7% after filing to sell 15M shares of common stock for holders.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
August 25, 2015
09:59 EDTMTZOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:59 EDTSFMOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:51 EDTSFMSprouts Farmers Markets upgraded on valuation, momentum at Deutsche Bank
As noted earlier, Deutsche Bank upgraded Sprouts Farmers Market to Buy from Hold. The firm says that the stock's valuation is "very attractive." Deutsche believes that, given Sprouts' "attractive prices," the company can benefit from a decline in confidence among middle class consumers. The firm expects the company to regain momentum ,and raised its price target on the name to $24 from $20.
06:21 EDTSFMSprouts Farmers Markets upgraded to Buy from Hold at Deutsche Bank
August 24, 2015
18:55 EDTNUANOn The Fly: After Hours Movers
Subscribe for More Information
16:11 EDTMTZMasTec initiated with a Neutral at Baird
Subscribe for More Information
10:37 EDTCALLMorgan Stanley reports 5.1% passive stake in magicJack
Subscribe for More Information
08:31 EDTHALOHalozyme names Michael LaBarre chief scientific officer
Halozyme named Michael J. LaBarre, Ph.D. as chief scientific officer, succeeding Dr. Michael Shepard, who was appointed a Research Fellow for the company. "Mike has deep experience characterizing early stage assets, making him an ideal leader for our research organization as we invest further in our promising pipeline," said Dr. Helen Torley, president and chief executive officer. "We have a full agenda for the second half of 2015 as we broaden the study of our investigational new drug PEGPH20 in multiple tumor types and prepare for our pivotal phase 3 study in pancreatic cancer patients. I am pleased to have a proven leader of Mike's caliber to guide our research efforts as we invest for future growth."
07:07 EDTGALEIDMC recommends reduction of cardiac toxicity monitoring in Galena NeuVax trial
Galena Biopharma announced that the Independent Data Monitoring Committee, or IDMC, has recommended to the company that it can reduce the cardiac toxicity monitoring for patients in its NeuVax Phase 3 Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment, or PRESENT, clinical trial. The trial is being run under a Special Protocol Assessment, or SPA, approved by the FDA. Following its most recent IDMC meeting in June, the IDMC recommended routine cardiac monitoring could be reduced in the PRESENT trial and that such a reduction is justified and consistent with the pre-specified Cardiac Toxicity Monitoring Stopping Rules defined in the study protocol. The IDMC concluded that cardiac toxicity monitoring by echocardiogram, or ECHO, or multiple-gated acquisition, or MUGA, scans could be reduced. The IDMC had no other suggestions and recommended the trial continue as planned.
August 21, 2015
09:01 EDTTRAKCox Automotive, DealerTrack announce extension of tender offer
Subscribe for More Information
August 20, 2015
09:05 EDTTRAKDealerTrack to sell Inventory+ business to DealerSocket for approx. $55M
Subscribe for More Information
August 19, 2015
13:30 EDTCEMPOn The Fly: Top stock stories at midday
Subscribe for More Information
07:02 EDTCEMPCempra granted fast track designation by FDA for solithromycin
Subscribe for More Information
August 17, 2015
19:00 EDTMTZOn The Fly: After Hours Movers
UP AFTER EARNINGS: Fabrinet (FN), up 5.1%. ALSO HIGHER: Esperion Therapeutics (ESPR), up 10.6% after announcing that it is on track to initiate ETC-1002 Phase 3 program by the end of 2015... Seattle Genetics (SGEN), up 3.3% after announcing FDA approval of Adcetris for HL treatment. DOWN AFTER EARNINGS: MasTec (MTZ), down 7.4%... Urban Outfitters (URBN), down 2.3%. ALSO LOWER: Sunedison (SUNE), down 1% after announcing a $500M perpetual convertible preferred stock offering.
16:41 EDTMTZMasTec cuts FY15 adjusted EPS to 73c-83c from $1.45, consensus $1.14
Cuts FY15 revenue to $4.2B-$4.3B from $4.4B, consensus $4.41B.
16:38 EDTMTZMasTec sees Q3 adjusted EPS 31c-37c, consensus 48c
Subscribe for More Information
16:37 EDTMTZMasTec reports Q2 adjusted EPS 10c, consensus 15c
Subscribe for More Information
14:48 EDTMTZNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Agilent (A), consensus 41c... Urban Outfitters (URBN), consensus 49c... MasTec (MTZ), consensus 15c... Fabrinet (FN), consensus 39c.
10:10 EDTCALLHigh option volume stocks
Subscribe for More Information
07:34 EDTNUANLeerink to hold a bus tour
Subscribe for More Information
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use